aTyr Pharma Announces Workforce Reduction Of About 60% To Focus On Efzofitimod Program; Expects $13M Reduction In Annualized Operating Expenses Beginning Q4 2026

Benzinga Newsdesk www.benzinga.com Negative 96.5%

Neg 96.5% Neu 0% Pos 0%

Comments

No comments yet. Be the first!